Dyslipidemia in Chronic Kidney Disease

被引:0
作者
Sainani, Pardeep [1 ]
Das, Bhagwan [2 ]
Kumar, Santosh [1 ]
Junejo, Abdul Manan [1 ]
Memon, Rafia [2 ]
Bai, Sapna [1 ]
机构
[1] Jinnah Postgrad Med Ctr, Dept Nephrol, Karachi, Pakistan
[2] Liaquat Univ Med & Hlth Sci, Dept Nephrol, Jamshoro, Pakistan
来源
PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES | 2021年 / 15卷 / 09期
关键词
Dyslipidemia; Chronic kidney disease (CKD); Cholesterol; Low density lipoprotein (LDL); High density lipoprotein (HDL); Hypertriglyceridemia; LIPID NEPHROTOXICITY; RENAL DYSFUNCTION; CHOLESTEROL; RISK; PROGRESSION; DIET;
D O I
10.53350/pjmhs211592541
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine the frequency for pattern of dyslipidemia in patients with chronic kidney disease. Study Design: Descriptive, cross-sectional Place and Duration of Study: Department of Nephrology, Jinnah Postgraduate Medical Centre (JPMC) from 26th December 2018to 28th June 2019. Methodology: One hundred and thirty-two patients were enrolled. Blood sample of 5 ml of each patient was taken and sent to the institutional pathology laboratory for measurement of lipid profile and pattern of dyslipidemia i.e. high cholesterol, low HDL, high LDL, hypertriglyceridemia was noted. Results: The mean age was 44.68 +/- 9.39 years and mean of duration of chronic kidney disease was 5.13 +/- 2.19 months. Seventy eight (59%) were males and 54 (41%) were females. Pattern of dyslipidemia i.e. high cholesterol, low HDL, high LDL and hypertriglyceridemia were documented in 89 (67.4%), 61 (46.2%), 65 (49.2%) and 37 (28.0%) patients respectively. Conclusion: Dyslipidemia is common among patients with chronic kidney disease is considerable. Regular evaluation of all chronic kidney disease patients for dyslipidemia and treatment need to be instituted.
引用
收藏
页码:2541 / 2543
页数:3
相关论文
共 50 条
[41]   Efficacy and safety of the PCSK9 inhibitors in the treatment of dyslipidemia in chronic kidney disease [J].
Quiroga, Borja ;
Munoz Ramos, Patricia ;
Alvarez Chiva, Vicente .
NEFROLOGIA, 2020, 40 (05) :499-505
[42]   Dyslipidemia, carotid intima-media thickness and endothelial dysfunction in children with chronic kidney disease [J].
Khandelwal, Priyanka ;
Murugan, Vijaya ;
Hari, Smriti ;
Lakshmy, Ramakrishnan ;
Sinha, Aditi ;
Hari, Pankaj ;
Bagga, Arvind .
PEDIATRIC NEPHROLOGY, 2016, 31 (08) :1313-1320
[43]   Dyslipidemia in Chronic Kidney Disease: Managing a High-Risk Combination [J].
Chauhan, Veeraish ;
Vaid, Megha .
POSTGRADUATE MEDICINE, 2009, 121 (06) :54-61
[44]   Chronic Kidney Disease and Pregnancy [J].
Hladunewich, Michelle A. .
SEMINARS IN NEPHROLOGY, 2017, 37 (04) :337-346
[45]   The association between dyslipidemia and the incidence of chronic kidney disease in the general Zhejiang population: a retrospective study [J].
Liang, Xudong ;
Ye, Meiyu ;
Tao, Mei ;
Zheng, Danna ;
Cai, Ruyi ;
Zhu, Yifan ;
Jin, Juan ;
He, Qiang .
BMC NEPHROLOGY, 2020, 21 (01)
[46]   Effect of Lipid-Lowering Drugs on Renal and Cardiovascular Outcomes in Patients with Chronic Kidney Disease and Dyslipidemia: A Retrospective Cohort Study [J].
Lin, Yi-Chih ;
Tsao, Hsiao-Mei ;
Lai, Tai-Shuan ;
Chen, Yi-Ting ;
Chou, Yu-Hsiang ;
Lin, Shuei-Liong ;
Chen, Yung-Ming ;
Hung, Kuan-Yu ;
Tu, Yu-Kang .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 114 (06) :1366-1374
[47]   The Tacrolimus Metabolism Rate and Dyslipidemia after Kidney Transplantation [J].
Thoelking, Gerold ;
Schulte, Christian ;
Jehn, Ulrich ;
Schuette-Nuetgen, Katharina ;
Pavenstaedt, Hermann ;
Suwelack, Barbara ;
Reuter, Stefan .
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (14)
[48]   Status of Lipid Profile in Different Stages of Chronic Kidney Disease [J].
Noor, Sabeela ;
Zuberi, Nudrat Anwar ;
Fatima, Fasiha ;
Iqbal, Tahseen ;
Khalilullah .
ANNALS ABBASI SHAHEED HOSPITAL & KARACHI MEDICAL & DENTAL COLLEGE, 2014, 19 (02) :62-66
[49]   Treatment and impact of dyslipidemia in diabetic nephropathy [J].
Toyama, Tadashi ;
Shimizu, Miho ;
Furuichi, Kengo ;
Kaneko, Shuichi ;
Wada, Takashi .
CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2014, 18 (02) :201-205
[50]   Effects of statin therapy on cerebrovascular and renal outcomes in patients with predialysis advanced chronic kidney disease and dyslipidemia [J].
Chung, Chang-Min ;
Lin, Ming-Shyan ;
Hsu, Jen-Te ;
Hsiao, Ju-Feng ;
Chang, Shih-Tai ;
Pan, Kuo-Li ;
Lin, Chun-Liang ;
Lin, Yu-Sheng .
JOURNAL OF CLINICAL LIPIDOLOGY, 2017, 11 (02) :422-431